Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Advanced Nutriceuticals, LLC: Various Injectable Peptides and Vitamins Recalled for Sterility Concerns

Agency Publication Date: December 11, 2020
Share:
Sign in to monitor this recall

Summary

Advanced Nutriceuticals, LLC is recalling 35 total units of various injectable medications, including CJC-1295, B12, and Thymosin, due to production process concerns that cannot guarantee the products are sterile. These products were distributed to clinics like The Guyer Institute of Molecular Medicine in 5ml, 10ml, and smaller vials. Consumers who have these products should be aware that using non-sterile injectable drugs can lead to serious infections at the injection site or throughout the body.

Risk

Injectable products that are not sterile pose a significant risk of serious infection or illness because the medication is delivered directly into the body's tissues or bloodstream. No specific injuries have been reported to date, but the lack of sterility assurance means the products may contain harmful microorganisms.

What You Should Do

  1. Check your medication vials for the following specific product names: CJC-1295, FGL, PT-141, AOD-9604, BPC-157, Thymosin Alpha, Ipamorelin, GHRP, Nandrolone, B12 for Injection, DSIP, Cerebrolysin, Thymosin Beta-4, GHK-CU, High Dose B12, LL-37, or Pentosan Polysulfate.
  2. Verify the lot numbers and expiration dates on your packaging. Affected lots include 1029202004, 1102202001, 1105202009, 1110202003, 1112202004 (CJC-1295); 1112202006 (FGL/PT-141); 1029202003, 1110202002, 1112202001 (AOD-9604); 1102202009, 1110202001 (BPC-157); 110220200, 1110202008 (Thymosin Alpha); 1029202005, 1102202014, 1112202002 (Ipamorelin); 1112202008 (GHRP); 1113202002, 1102202005 (Nandrolone); 1111202001 (B12); 1111202002 (DSIP); 1110202004 (Cerebrolysin); 1110202005, 1102202015 (Thymosin Beta-4); 1030202010 (GHK-CU); 1029202007 (High Dose B12); 1105202006 (LL-37); and 1110202006 (Pentosan Polysulfate).
  3. Immediately stop using any affected products and contact your healthcare provider or pharmacist for guidance regarding your treatment and potential alternative medications.
  4. Return any unused vials to the pharmacy or medical facility where you received them for a full refund and further instructions.
  5. Contact Advanced Nutriceuticals, LLC or the distributor, The Guyer Institute of Molecular Medicine, for more information about the return process.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Drug recall baseline remedy

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: CJC-1295 (2000 MCG/ML, 5 ML vial)
Model:
Recall #: D-0128-2021
Lot Numbers:
1029202004 (Exp 11/29/2020)
1102202001 (Exp 12/08/2020)
102202009 (Exp 12/08/2020)
1105202009 (Exp 12/20/2020)
1110202003 (Exp 12/10/2020)
1112202004 (Exp 12/12/2020)
Product: FGL (10 MG/ML, 3 ML vial)
Model:
Recall #: D-0129-2021
Lot Numbers:
1112202006 (Exp 12/12/2020)
Product: PT-141 (10 MG/ML, 2 ML vial)
Model:
Recall #: D-0130-2021
Lot Numbers:
1112202006 (Exp 12/12/2020)
Product: AOD-9604 (1200 MCG/ML, 5 ML vial)
Model:
Recall #: D-0131-2021
Lot Numbers:
1029202003 (Exp 11/29/2020)
1110202002 (Exp 12/10/2020)
1112202001 (Exp 12/12/2020)
Product: BPC-157 (2000 MCG/ML, 5 ML vial)
Model:
Recall #: D-0132-2021
Lot Numbers:
1102202009 (Exp 12/08/2020)
1105202009 (Exp 12/20/2020)
1110202001 (Exp 12/15/2020)
1112202004 (Exp 12/12/2020)
Product: THYMOSIN ALPHA (2000 MCG/ML, 5 ML vial)
Model:
Recall #: D-0133-2021
Lot Numbers:
110220200 (Exp 12/09/2020)
1102202009 (Exp 12/09/2020)
1105202009 (Exp 12/20/2020)
1110202008 (Exp 12/10/2020)
Product: IPAMORELIN (2000 MCG/ML, 5 ML vial)
Model:
Recall #: D-0134-2021
Lot Numbers:
1029202005 (Exp 11/29/2020)
1102202014 (Exp 12/08/2020)
1112202002 (Exp 12/12/2020)
Product: GHRP (2000 MCG/ML, 5 ML vial)
Model:
Recall #: D-0135-2021
Lot Numbers:
1112202008 (Exp 12/11/2020)
Product: NANDROLONE (200 MCG/ML, 2 ML)
Model:
Recall #: D-0136-2021
Lot Numbers:
1113202002 (Exp 01/13/2021)
1102202005 (Exp 12/08/2020)
Product: B12 for Injection (2 MG/ML, 10 ML vial)
Model:
Recall #: D-0137-2021
Lot Numbers:
1111202001 (Exp 01/11/2021)
Product: DSIP (1000 MCG/ML, 5 ML vial)
Model:
Recall #: D-0138-2021
Lot Numbers:
1111202002 (Exp 12/11/2020)
Product: CEREBROLYSIN (107.5 MG/ML, 10 ML vial)
Model:
Recall #: D-0139-2021
Lot Numbers:
1110202004 (Exp 12/10/2020)
Product: THYMOSIN BETA - 4 (2000 MCG/ML, 5 ML vial)
Model:
Recall #: D-0140-2021
Lot Numbers:
1110202005 (Exp 12/10/2020)
1102202015 (Exp 12/08/2020)
1105202009 (Exp 12/20/2020)
Product: GHK-CU (10 MG/ML, 5 ML vial)
Model:
Recall #: D-0141-2021
Lot Numbers:
1030202010 (Exp 11/30/2020)
Product: HIGH DOSE B12 (10 MG/ML, 10 ML vial)
Model:
Recall #: D-0142-2021
Lot Numbers:
1029202007 (Exp 12/29/20)
Product: LL-37 (2000 MCG/ML, 2 ML vial)
Model:
Recall #: D-0143-2021
Lot Numbers:
1105202006 (Exp 12/18/2020)
Product: Pentosan Polysulfate (300 MG/ML, 5 ML vial)
Model:
Recall #: D-0144-2021
Lot Numbers:
1110202006 (Exp 12/10/2020)

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 86799
Status: Active
Manufacturer: Advanced Nutriceuticals, LLC
Sold By: The Guyer Institute of Molecular Medicine
Manufactured In: United States
Units Affected: 17 products (6 vials; 1 vial; 1 vial; 3 vials; 4 vials; 4 vials; 3 vials; 1 vial; 2 vials; 1 vials; 1 vial; 1 vial; 3 vials; 1 vial; 1 vials; 1 vial; 1 vial)
Distributed To: California, Colorado, Florida, Indiana, Kentucky, Ohio, Texas

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.